Author:
Elnaggar Mohamed G.,Mosad Eman,Makboul Ahmed,Shafik Engy Adel
Abstract
Abstract
Background
Acute myeloid leukemia (AML) is a diverse disease characterized by the expansion of blasts of myeloid lineage. Cytogenetic testing is the cornerstone for risk stratification of AML patients. Geographical and environmental factors may play a very important role in the development of leukemia and several differences in genetic profile may be seen among different ethnicities. In our study, we evaluated cytogenetic findings of adult AML patients in South Egypt.
Methods
Cytogenetic testing (karyotyping and M-FISH) was performed for 120 adult patients with AML. Twenty metaphases were analyzed for each patient.
Results
In our study, the median age of AML patients was 36.5 years, with an age range between 18 and 86 years. 56.7% of patients had normal karyotypes and 43.3% of patients had clonal cytogenetic abnormalities. t (15;17) was the most detected structural abnormality, and + 8 was the most detected numerical abnormality. Regarding cytogenetic risk stratification, 65% of patients were in the intermediate-risk category.
Conclusion
The cytogenetic profile of AML patients in our locality showed some differences and some similarities with cytogenetic profiles in different Arab, Asian and Western countries. Further studies are needed using advanced techniques such as next-generation sequencing and optical genome mapping to elucidate more ethnic and geographic genetic heterogeneity among different countries.
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,Biochemistry
Reference35 articles.
1. Meillon-Garcia LA, Demichelis-Gomez R. Access to therapy for acute myeloid leukemia in the developing world: barriers and solutions. Curr Oncol Rep. 2020;22(12):125. https://doi.org/10.1007/s11912-020-00987-8.
2. Hoffmann J, Qin D, Cagle PT. Acute myeloid leukemia with recurrent genetic abnormalities: part I cytogenetic abnormalities. In: Chang CCJ, Ohgami RS, editors. Precision molecular pathology of myeloid neoplasms. Switzerland: Springer International Publishing; 2018. p. 1–26.
3. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354–65. https://doi.org/10.1182/blood-2009-11-254441.
4. Mrozek K, Heinonen K, Bloomfield CD. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia. Int J Hematol. 2000;72(3):261–71.
5. Sierra M, Alonso Á, Odero MD, Gonzalez MB, Lahortiga I, Pérez JJ, et al. Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain. Leuk Res. 2006;30(8):943–8. https://doi.org/10.1016/j.leukres.2005.12.025.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献